Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack

Completed · Not applicable

Conditions studied: Anterior Wall Acute Myocardial Infarction

In brief

The purpose of this study is to evaluate the feasibility of the delivery of SuperSaturated Oxygen (SSO2) Therapy for 60 minutes selectively into the left main coronary artery (LMCA). The therapy will be delivered with a commercially available qualified SSO2 delivery catheter used with the TherOx® DownStream® System and Cartridge in the treatment of patients presenting with an anterior acute myocardial infarction (heart attack) ≤ six hours after symptom onset with successful reperfusion (via PCI).

Key facts

Study ID

NCT01630707

Run by

TherOx

People needed

20

Starts

2012-08-01

Expected to finish

2014-08-01

Last updated by the study team

2026-05-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Scottsdale Healthcare — Scottsdale, Arizona, United States
• Beaumont Hospital, Royal Oak — Royal Oak, Michigan, United States
• Providence Hospital and Medical Centers — Southfield, Michigan, United States
• Wellmont Holston Valley Medical Center — Kingsport, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.